Nathan C A, Carter P, Liu L, Li B D, Abreo F, Tudor A, Zimmer S G, De Benedetti A
Department of Biochemistry, LSU Medical Center, Shreveport, Louisiana, USA.
Oncogene. 1997 Aug 28;15(9):1087-94. doi: 10.1038/sj.onc.1201272.
The translation initiation factor eIF4E is a novel protooncogene found over expressed in most breast carcinomas (Kerekatte et al., 1995), but the pathology where this elevation is initially manifested and its possible role in cancer progression are unknown. We report that eIF4E is markedly increased in vascularized malignant ductules of invasive carcinomas, whereas necrotic and avascular ductal carcinomas in situ display significantly lower levels. eIF4E facilitates the synthesis of FGF-2, a powerful tumor angiogenic factor. Conversely, reducing eIF4E with antisense RNA in MDA-435 cells suppresses their tumorigenic and angiogenic properties, consistent with loss of FGF-2 synthesis. These findings suggest a causal role for eIF4E in tumor vascularization.
翻译起始因子eIF4E是一种新发现的原癌基因,在大多数乳腺癌中过度表达(Kerekatte等人,1995年),但其最初表现出这种升高的病理学情况及其在癌症进展中的可能作用尚不清楚。我们报告,在浸润性癌的血管化恶性小导管中,eIF4E显著增加,而坏死性和无血管原位导管癌的水平则显著较低。eIF4E促进强大的肿瘤血管生成因子FGF-2的合成。相反,在MDA-435细胞中用反义RNA降低eIF4E可抑制其致瘤和血管生成特性,这与FGF-2合成的丧失一致。这些发现表明eIF4E在肿瘤血管形成中起因果作用。